BIOMAT Database Logo BIOMAT Database Logo

Heparin-like macromolecules for the modification of anticoagulant biomaterials. 2012

Fen Ran, and Shengqiang Nie, and Jie Li, and Baihai Su, and Shudong Sun, and Changsheng Zhao
College of Polymer Science and Engineering, State Key Laboratory of Polymer Materials Engineering, Sichuan University, Chengdu, China.

A heparin-like structured macromolecule (HLSM) is synthesized by RAFT polymerization using carboxyl-terminated trithiocarbonate as the RAFT agent. The HLSM can be directly blended with PES in DMAC to prepare flat-sheet membrane by means of a liquid-liquid phase separation technique. The synthesized polymeric material retard blood clotting and the modified membrane exhibits good anticoagulant ability due to the existence of the important functional groups SO(3) H, COOH and OH. The anionic groups on the membrane surface may bind coagulation factors and thus improve anticoagulant ability. The results indicate that the HLSM has potential to improve the anticoagulant properties of biomaterials and to be applied in blood purification including hemodialysis and bioartificial liver supports.

UI MeSH Term Description Entries
D010973 Platelet Adhesiveness The process whereby PLATELETS adhere to something other than platelets, e.g., COLLAGEN; BASEMENT MEMBRANE; MICROFIBRILS; or other "foreign" surfaces. Adhesiveness, Platelet,Adhesivenesses, Platelet,Platelet Adhesivenesses
D011108 Polymers Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., BIOPOLYMERS; PLASTICS). Polymer
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D001672 Biocompatible Materials Synthetic or natural materials, other than DRUGS, that are used to replace or repair any body TISSUES or bodily function. Biomaterials,Bioartificial Materials,Hemocompatible Materials,Bioartificial Material,Biocompatible Material,Biomaterial,Hemocompatible Material,Material, Bioartificial,Material, Biocompatible,Material, Hemocompatible
D013450 Sulfones Sulfone
D013499 Surface Properties Characteristics or attributes of the outer boundaries of objects, including molecules. Properties, Surface,Property, Surface,Surface Property
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Fen Ran, and Shengqiang Nie, and Jie Li, and Baihai Su, and Shudong Sun, and Changsheng Zhao
Heparin-like anticoagulant associated with AIDS.
April 1987, Thrombosis and haemostasis,
Fen Ran, and Shengqiang Nie, and Jie Li, and Baihai Su, and Shudong Sun, and Changsheng Zhao
[Control of anticoagulant therapy with heparin and heparin-like substances].
November 1951, Il Progresso medico,
Fen Ran, and Shengqiang Nie, and Jie Li, and Baihai Su, and Shudong Sun, and Changsheng Zhao
The heparin-like activity of a new anticoagulant, treburon.
July 1951, The Journal of pharmacology and experimental therapeutics,
Fen Ran, and Shengqiang Nie, and Jie Li, and Baihai Su, and Shudong Sun, and Changsheng Zhao
Phosphotungstate shows a heparin-like anticoagulant effect but inhibits heparin.
August 1989, Thrombosis research,
Fen Ran, and Shengqiang Nie, and Jie Li, and Baihai Su, and Shudong Sun, and Changsheng Zhao
Microvascular heparin-like species with anticoagulant activity.
November 1983, The American journal of physiology,
Fen Ran, and Shengqiang Nie, and Jie Li, and Baihai Su, and Shudong Sun, and Changsheng Zhao
Heparin-like anticoagulant associated with systemic candidiasis.
September 1990, American journal of hematology,
Fen Ran, and Shengqiang Nie, and Jie Li, and Baihai Su, and Shudong Sun, and Changsheng Zhao
Circulating heparin-like anticoagulant following portacaval anastomosis.
September 1970, Lancet (London, England),
Fen Ran, and Shengqiang Nie, and Jie Li, and Baihai Su, and Shudong Sun, and Changsheng Zhao
Anticoagulant heparin-like glycosaminoglycans on endothelial cell surface.
October 1991, Japanese circulation journal,
Fen Ran, and Shengqiang Nie, and Jie Li, and Baihai Su, and Shudong Sun, and Changsheng Zhao
[Heparin-like anticoagulant in small cell bronchial carcinoma].
January 1991, La Revue de medecine interne,
Fen Ran, and Shengqiang Nie, and Jie Li, and Baihai Su, and Shudong Sun, and Changsheng Zhao
Heparin-like anticoagulant associated with plasma cell myeloma.
June 1985, American journal of clinical pathology,
Copied contents to your clipboard!